142 related articles for article (PubMed ID: 37556121)
1. The c.415C>T polymorphism in NUDT15 is more frequent than the polymorphisms in TPMT in Chilean patients who use thiopurine drugs.
von Muhlenbrock C; Estay C; Covarrubias N; Miranda J; Venegas M
Pharmacogenet Genomics; 2023 Sep; 33(7):161-163. PubMed ID: 37556121
[TBL] [Abstract][Full Text] [Related]
2. NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease.
Lee YJ; Hwang EH; Park JH; Shin JH; Kang B; Kim SY
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):475-8. PubMed ID: 26735160
[TBL] [Abstract][Full Text] [Related]
3. Further evidence that a variant of the gene NUDT15 may be an important predictor of azathioprine-induced toxicity in Chinese subjects: a case report.
Ailing Z; Jing Y; Jingli L; Yun X; Xiaojian Z
J Clin Pharm Ther; 2016 Oct; 41(5):572-4. PubMed ID: 27381176
[TBL] [Abstract][Full Text] [Related]
4. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon.
Zgheib NK; Akika R; Mahfouz R; Aridi CA; Ghanem KM; Saab R; Abboud MR; Tarek N; El Solh H; Muwakkit SA
Pediatr Blood Cancer; 2017 Jan; 64(1):146-150. PubMed ID: 27577869
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis.
Jena A; Jha DK; Kumar-M P; Kasudhan KS; Kumar A; Sarwal D; Mishra S; Singh AK; Bhatia P; Patil A; Sharma V
Expert Rev Clin Pharmacol; 2021 Apr; 14(4):491-501. PubMed ID: 33682590
[No Abstract] [Full Text] [Related]
6. Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
Zhou H; Li L; Yang P; Yang L; Zheng JE; Zhou Y; Han Y
BMC Cancer; 2018 May; 18(1):516. PubMed ID: 29720126
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Direct Sequencing, Real-Time PCR-High Resolution Melt (PCR-HRM) and PCR-Restriction Fragment Length Polymorphism (PCR-RFLP) Analysis for Genotyping of Common Thiopurine Intolerant Variant Alleles NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C).
Fong WY; Ho CC; Poon WT
Diagnostics (Basel); 2017 May; 7(2):. PubMed ID: 28498350
[TBL] [Abstract][Full Text] [Related]
8. Nucleoside diphosphate-linked moiety X-type motif 15 C415T variant as a predictor for thiopurine-induced toxicity in Indian patients.
Shah SA; Paradkar M; Desai D; Ashavaid TF
J Gastroenterol Hepatol; 2017 Mar; 32(3):620-624. PubMed ID: 27416873
[TBL] [Abstract][Full Text] [Related]
9. TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India.
Grover N; Bhatia P; Kumar A; Singh M; Lad D; Mandavdhare HS; Samanta J; Prasad KK; Dutta U; Sharma V
BMC Gastroenterol; 2021 Aug; 21(1):327. PubMed ID: 34425754
[TBL] [Abstract][Full Text] [Related]
10. Comparison of
Wang HH; He Y; Wang HX; Liao CL; Peng Y; Tao LJ; Zhang W; Yang HX
World J Gastroenterol; 2018 Feb; 24(8):941-948. PubMed ID: 29491687
[TBL] [Abstract][Full Text] [Related]
11. Severe thiopurine-induced leukocytopenia and hair loss in Japanese patients with defective NUDT15 variant: Retrospective case-control study.
Kishibe M; Nozaki H; Fujii M; Iinuma S; Ohtsubo S; Igawa S; Kanno K; Honma M; Kishibe K; Okamoto K; Ishida-Yamamoto A
J Dermatol; 2018 Oct; 45(10):1160-1165. PubMed ID: 30101994
[TBL] [Abstract][Full Text] [Related]
12. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients.
Sutiman N; Chen S; Ling KL; Chuah SW; Leong WF; Nadiger V; Tjai M; Choon Kong CS; Schwender BJ; Chan W; Shim HH; Lim WC; Khor CC; Cheung YB; Chowbay B
Pharmacogenomics; 2018 Jan; 19(1):31-43. PubMed ID: 29210335
[TBL] [Abstract][Full Text] [Related]
13. [Effect of genetic polymorphism of TPMT and NUDT15 on the tolerance of 6-mercaptopurine therapy in adult acute lymphoblastic leukemia].
Hao QS; Wang Z; Fang QY; Gong XY; Liu KQ; Li Y; Wei H; Wang Y; Li QH; Wang M; Tian Z; Wang JX; Mi YC
Zhonghua Xue Ye Xue Za Zhi; 2021 Nov; 42(11):911-916. PubMed ID: 35045652
[No Abstract] [Full Text] [Related]
14. Pharmacogenetic determinants of thiopurines in an Indian cohort.
Naushad SM; Janaki Ramaiah M; Kutala VK; Hussain T; Alrokayan SA
Pharmacol Rep; 2021 Feb; 73(1):278-287. PubMed ID: 32935219
[TBL] [Abstract][Full Text] [Related]
15. Preemptive NUDT15 genotyping: redefining the management of patients with thiopurine-induced toxicity.
Shah SAV; Paradkar MU; Desai DC; Ashavaid TF
Drug Metab Pers Ther; 2018 Mar; 33(1):57-60. PubMed ID: 29470173
[TBL] [Abstract][Full Text] [Related]
16. Effects of
Mao X; Yin R; Sun G; Zhou Y; Yang C; Fang C; Wu Y; Cui T; Liu L; Gan J; Tian X
Front Pediatr; 2021; 9():719803. PubMed ID: 34660484
[No Abstract] [Full Text] [Related]
17. Pharmacogeomic implications of population diversity in Latin America: TPMT and NUDT15 polymorphisms and thiopurine dosing.
Suarez-Kurtz G; Araújo GS; de Sousa SJ
Pharmacogenet Genomics; 2020 Jan; 30(1):1-4. PubMed ID: 31651720
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of 6-mercaptopurine in a black Zimbabwean cohort treated for acute lymphoblastic leukaemia.
Chikondowa P; Munkombwe D; Chikwambi Z; Kuona P; Masimirembwa C
Pharmacogenomics; 2023 Jun; 24(8):449-457. PubMed ID: 37248698
[TBL] [Abstract][Full Text] [Related]
19. NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine-induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India.
Banerjee R; Ravikanth VV; Pal P; Bale G; Avanthi US; Goren I; Girish BG; Mitnala S; Reddy DN
Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1683-1694. PubMed ID: 33111378
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations.
Maillard M; Nishii R; Yang W; Hoshitsuki K; Chepyala D; Lee SHR; Nguyen JQ; Relling MV; Crews KR; Leggas M; Singh M; Suang JLY; Yeoh AEJ; Jeha S; Inaba H; Pui CH; Karol SE; Trehan A; Bhatia P; Antillon Klussmann FG; Bhojwani D; Haidar CE; Yang JJ
J Natl Cancer Inst; 2024 May; 116(5):702-710. PubMed ID: 38230823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]